THCT (THC Therapeutics) Debt-to-Asset : 66.55 (As of Jul. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is THC Therapeutics Debt-to-Asset?

THC Therapeutics THCT Debt-to-Asset is 66.55 as of Jul. 2024.

THC Therapeutics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2024 was $0.73 Mil. THC Therapeutics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2024 was $0.00 Mil. THC Therapeutics's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jul. 2024 was $0.01 Mil. THC Therapeutics's debt to asset for the quarter that ended in Jul. 2024 was 66.55.

THC Therapeutics  (OTCPK:THCT) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

THC Therapeutics Debt-to-Asset Related Terms

THC Therapeutics Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for THC Therapeutics's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Therapeutics Debt-to-Asset Chart

THC Therapeutics Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.06 1.59 3.87 56.31 66.55

THC Therapeutics Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.31 61.00 48.80 61.00 66.55

THCT vs ZTS, UTHR, NBIX: Debt-to-Asset Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, THC Therapeutics's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

THC Therapeutics Debt-to-Asset vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, THC Therapeutics's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where THC Therapeutics's Debt-to-Asset falls into.


THC Therapeutics Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

THC Therapeutics's Debt-to-Asset for the fiscal year that ended in Jul. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.732 + 0) / 0.011
=66.55

THC Therapeutics's Debt-to-Asset for the quarter that ended in Jul. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.732 + 0) / 0.011
=66.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 66.55 mean?
THC Therapeutics (THCT) has a Debt-to-Asset of 66.55 as of Jul. 2024. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on THC Therapeutics and its competitors.
Is THC Therapeutics' Debt-to-Asset too high?
THC Therapeutics' current Debt-to-Asset is 66.55.
How does THC Therapeutics' Debt-to-Asset compare to ZTS and UTHR?
THC Therapeutics' Debt-to-Asset of 66.55 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Drug Manufacturers company?
A good Debt-to-Asset depends on the Drug Manufacturers industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on THC Therapeutics and its competitors. THC Therapeutics's current Debt-to-Asset is 66.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is THC Therapeutics stock overvalued right now?
THC Therapeutics (THCT) has a current Debt-to-Asset of 66.55. The current Debt-to-Asset is 66.55. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For THC Therapeutics (THCT), the current Debt-to-Asset is 66.55 as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

THC Therapeutics Business Description

Address 203 S Church Steet, Jacksboro, TX, USA, 76458
Website https://thct.io
THC Therapeutics Inc is a United States-based company. It is focused on developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing i.e., reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis.